Chronic Hepatitis Intervention Project for Drug Users
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00596843|
Recruitment Status : Completed
First Posted : January 17, 2008
Last Update Posted : March 1, 2017
|Condition or disease||Intervention/treatment||Phase|
|HIV Hepatitis C||Behavioral: Motivational interviewing Behavioral: Educational intervention||Phase 3|
This 4.5-year community-based study is a randomized field experiment that uses a two-group design. Participants are randomized into either an Educational intervention group or a Motivational intervention group. We are comparing the effectiveness of the Motivational intervention with the Educational intervention. We are also estimating the costs and evaluating the cost-effectiveness of the Motivational intervention relative to the Educational intervention.
We have the following aims and related hypotheses:
Aim 1: To compare the effectiveness of a 6-session personalized motivational intervention to a 6-session educational intervention in terms of injection risk, sexual behavior, alcohol use, and knowledge and perception related to HBV and HCV; H1. Relative to the Educational intervention group, a greater proportion of the Motivational intervention group will report no injection risk at 6- and 12-month follow-up interviews. No injection risk is operationally defined as either no injections in the past 30 days, or no direct or indirect sharing of syringes and other injection equipment in the past 30 days.
H2. Relative to the Educational intervention group, a greater proportion of the Motivational intervention group will report no sexual risk at 6- and 12-month follow-up interviews. No sexual risk is operationally defined as either no sex (oral, vaginal, or anal) in the past 30 days, or no unprotected oral, vaginal, or anal sex in the past 30 days.
H3. Relative to the Educational intervention group, the Motivational intervention group will report greater decreases in frequency of alcohol consumption and quantity of alcohol consumed. Frequency of alcohol consumption is defined as "number of days drank alcohol in the past 30 days," and quantity of alcohol consumed is defined as "the average number of drinks per drinking day during the past 30 days." H4. Relative to the Educational intervention group, participants in the Motivational intervention group will report greater increases in knowledge and more accurate perceptions of severity of disease and efficacy of protective actions regarding hepatitis B and C at Session 3.
Aim 2: To estimate the cost and cost-effectiveness of a 6-session personalized motivational intervention relative to a 6-session educational intervention.
H5. The Motivational Intervention will cost more than the Educational Intervention, but will be cost-effective at eliminating injection risk behavior and sexual risk behavior and at reducing alcohol use
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||851 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||None (Open Label)|
|Official Title:||Chronic Hepatitis Intervention Project for Drug Users|
|Study Start Date :||September 2003|
|Actual Primary Completion Date :||November 2006|
|Actual Study Completion Date :||November 2006|
Behavioral: Motivational interviewing
6 one-on-one individual sessions lasting from 30 minutes to 1-hour each
Active Comparator: 2
Behavioral: Educational intervention
6 1-hour sessions. 2 sessions are delivered by an interventionist and 4 sessions are delivered as videos
- Reduction/cessation of alcohol use [ Time Frame: 6-months and 12-months ]
- Reductions in direct and indirect needle and syringe sharing [ Time Frame: 6-months and 12-months ]
- Reductions in unprotected sexual behavior [ Time Frame: 6-months and 12-months ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00596843
|United States, North Carolina|
|RTI International Field Site|
|Durham, North Carolina, United States|
|Principal Investigator:||William A. Zule, Dr.P.H.||RTI International|